Team delivers breakthrough nanobody technology medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Birmingham Platelet Group delivers breakthrough ‘nanobody’ technology October 12, 2023: Researchers led by Professor Steve Watson and Dr Eleyna Martin from the Institute of Cardiovascular Sciences at the University of Birmingham have delivered a breakthrough for thrombosis researchers, by producing.
Birmingham Group Achieves Breakthrough with Nanobody Tech miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
)
Suda Pharmaceuticals ends June quarter with $6.7 million in bank as it prepares to move forward its iNKT cell therapy platform licence
The biotechnology company released its fourth-quarter report, unveiling cash receipts for the quarter of $68,000 and net outflow of $909,000 from operating activities for the quarter. In June, its heavily oversubscribed placement raised $3.65 million, from the initial target of a minimum of $3 million.
Suda Pharmaceuticals Ltd has ended the June quarter with $6.717 million in cash as it prepares to move forward with its newly acquired invariant Natural Killer T (iNKT) cell therapy platform, initially for the treatment of blood cancers.
The biotechnology company released its fourth-quarter report, unveiling cash receipts for the quarter of $68,000 and net outflow of $909,000 from operating activities for the quarter.